| NCT Number | NCT06590896 |
| Lead Sponsor | Ono Pharmaceutical Co., Ltd. |
| Conditions | Epilepsies, Partial |
| Enrollment | 100 participants |
| Start Date | 2022-11-04 |
| Primary Completion | 2027-01-31 (estimated) |
| Study Completion | 2027-01-31 (estimated) |
| Updated on ClinicalTrials.gov | 2025-06-03 |